Some Confidence Is Lacking In Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros' (BME:LDA) P/S

There wouldn't be many who think Línea Directa Aseguradora, S.A., Compañía de Seguros y Reaseguros' (BME:LDA) price-to-sales (or "P/S") ratio of 1.1x is worth a mention when the median P/S for the Insurance industry in Spain is similar at about 1x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.

See our latest analysis for Línea Directa Aseguradora Compañía de Seguros y Reaseguros

ps-multiple-vs-industry
BME:LDA Price to Sales Ratio vs Industry April 30th 2024
Advertisement

How Línea Directa Aseguradora Compañía de Seguros y Reaseguros Has Been Performing

Recent times haven't been great for Línea Directa Aseguradora Compañía de Seguros y Reaseguros as its revenue has been rising slower than most other companies. It might be that many expect the uninspiring revenue performance to strengthen positively, which has kept the P/S ratio from falling. However, if this isn't the case, investors might get caught out paying too much for the stock.

Want the full picture on analyst estimates for the company? Then our free report on Línea Directa Aseguradora Compañía de Seguros y Reaseguros will help you uncover what's on the horizon.

What Are Revenue Growth Metrics Telling Us About The P/S?

The only time you'd be comfortable seeing a P/S like Línea Directa Aseguradora Compañía de Seguros y Reaseguros' is when the company's growth is tracking the industry closely.

Taking a look back first, we see that the company managed to grow revenues by a handy 3.1% last year. The solid recent performance means it was also able to grow revenue by 9.9% in total over the last three years. Accordingly, shareholders would have probably been satisfied with the medium-term rates of revenue growth.

Turning to the outlook, the next three years should generate growth of 1.8% each year as estimated by the six analysts watching the company. With the industry predicted to deliver 10% growth per year, the company is positioned for a weaker revenue result.

With this information, we find it interesting that Línea Directa Aseguradora Compañía de Seguros y Reaseguros is trading at a fairly similar P/S compared to the industry. It seems most investors are ignoring the fairly limited growth expectations and are willing to pay up for exposure to the stock. Maintaining these prices will be difficult to achieve as this level of revenue growth is likely to weigh down the shares eventually.

What We Can Learn From Línea Directa Aseguradora Compañía de Seguros y Reaseguros' P/S?

Using the price-to-sales ratio alone to determine if you should sell your stock isn't sensible, however it can be a practical guide to the company's future prospects.

When you consider that Línea Directa Aseguradora Compañía de Seguros y Reaseguros' revenue growth estimates are fairly muted compared to the broader industry, it's easy to see why we consider it unexpected to be trading at its current P/S ratio. When we see companies with a relatively weaker revenue outlook compared to the industry, we suspect the share price is at risk of declining, sending the moderate P/S lower. A positive change is needed in order to justify the current price-to-sales ratio.

There are also other vital risk factors to consider before investing and we've discovered 1 warning sign for Línea Directa Aseguradora Compañía de Seguros y Reaseguros that you should be aware of.

If strong companies turning a profit tickle your fancy, then you'll want to check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About BME:LDA

Línea Directa Aseguradora Compañía de Seguros y Reaseguros

Engages in insurance and reinsurance business in Spain and Portugal.

Solid track record with adequate balance sheet.

Advertisement

Weekly Picks

VA
valuebull
GOAI logo
valuebull on Eva Live ·

Is this the AI replacing marketing professionals?

Fair Value:US$7.4347.9% undervalued
45 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative
TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3956.5% undervalued
23 users have followed this narrative
3 users have commented on this narrative
23 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.2k% overvalued
31 users have followed this narrative
7 users have commented on this narrative
24 users have liked this narrative
AH
LLY logo
AHaron on Eli Lilly ·

Eli Lilly: A Pipeline-Driven Growth Story Trading 30% Below What the Business Is Actually Worth

Fair Value:US$1.48k35.4% undervalued
16 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative

Updated Narratives

IN
LUCD logo
InvestingNurse on Lucid Diagnostics ·

Poised for success

Fair Value:US$577.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.674.5% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
OS
GRDM logo
osborne820 on Grid Metals ·

Grid Metals will see a transformative 21.5x future PE change

Fair Value:CA$0.7584.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9832.0% undervalued
51 users have followed this narrative
0 users have commented on this narrative
36 users have liked this narrative
PD
VRT logo
pdixit1 on Vertiv Holdings Co ·

The Infrastructure AI Cannot Be Built Without

Fair Value:US$408.6436.5% undervalued
40 users have followed this narrative
3 users have commented on this narrative
18 users have liked this narrative
ZA
PME logo
ZayaanS on Pro Medicus ·

Pro Medicus: The Market Is Confusing a Lumpy Quarter With a Broken Business

Fair Value:AU$196.7837.0% undervalued
34 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative